首页> 外国专利> PROTEIN C AND ENDOTHELIAL PROTEIN C RECEPTOR POLYMORPHISMS AS INDICATORS OF PATIENT OUTCOME

PROTEIN C AND ENDOTHELIAL PROTEIN C RECEPTOR POLYMORPHISMS AS INDICATORS OF PATIENT OUTCOME

机译:蛋白C和内皮蛋白C受体多态性作为患者结果的指标

摘要

The invention provides methods and kits for obtaining a prognosis for apatient having orat risk of developing an inflammatory condition. The method generallycomprisesdetermining a protein C and/or EPCR genotype(s) of a patient for apolymorphisms in thethese genes, comparing the determined genotype with known genotypes for thepolymorphism that correspond with the ability of the patient to recover fromtheinflammatory condition and identifying patients based on their prognosis. Theinventionalso provides for methods of identifying other polymorphisms that correspondwith theability of the patient to recover from the inflammatory condition.
机译:本发明提供了用于获得预后的方法和试剂盒。患有或有发炎的危险。一般方法包含确定患者的蛋白C和/或EPCR基因型中的多态性这些基因,将确定的基因型与已知的基因型进行比较与患者恢复能力相对应的多态性的炎症状况并根据预后确定患者。的发明还提供了识别对应的其他多态性的方法与患者从炎症状态恢复的能力。

著录项

  • 公开/公告号CA2479968A1

    专利类型

  • 公开/公告日2006-03-01

    原文格式PDF

  • 申请/专利权人 THE UNIVERSITY OF BRITISH COLUMBIA;

    申请/专利号CA20042479968

  • 发明设计人 WALLEY KEITH R.;RUSSELL JAMES A.;

    申请日2004-09-01

  • 分类号C07H21;A61K45;A61P29;C12Q1/68;

  • 国家 CA

  • 入库时间 2022-08-21 21:35:29

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号